XML 68 R66.htm IDEA: XBRL DOCUMENT v2.4.0.8
Guarantor Financial Information (Condensed Consolidated Statements of Cash Flows) (Details) (USD $)
In Thousands, unless otherwise specified
9 Months Ended
Sep. 27, 2014
Sep. 28, 2013
Cash flows from operating activities:    
Net income/ (loss) $ (477) $ 86,474
Earnings in investments in subsidiaries 0 0
Other operating cash flows 179,774 82,231
Net cash provided by operating activities 179,297 168,705
Cash flows from investing activities:    
Capital expenditures (153,984) (85,719)
Acquisitions, net of cash acquired (2,075,651) (121,440)
Investment in unconsolidated subsidiary 0 (44,959)
Note receivable from affiliates 0  
Gross proceeds from disposal of property, plant and equipment and other assets 2,810 1,666
Proceeds from insurance settlements 1,550 1,981
Payments related to routes and other intangibles (8,210) (2,374)
Net cash used by investing activities (2,233,485) (250,845)
Cash flows from financing activities:    
Proceeds from long-term debt 1,836,917 0
Payments on long-term debt (310,773) (62)
Borrowings from revolving credit facility 170,143 0
Payments on revolving credit facility (277,254) 0
Net cash overdraft financing 933 0
Deferred loan costs (45,223) (11,138)
Issuance of common stock 417 32
Contributions from parent 0 0
Minimum withholding taxes paid on stock awards (6,814) (2,649)
Excess tax benefits from stock-based compensation 1,451 719
Net cash provided/ (used) by financing activities 1,369,797 (13,098)
Effect of exchange rate changes on cash and cash equivalents 6,961 0
Net increase/ (decrease) in cash and cash equivalents (677,430) (95,238)
Cash and cash equivalents at beginning of period 870,857 103,249
Cash and cash equivalents at end of period 193,427 8,011
Issuer [Member]
   
Cash flows from operating activities:    
Net income/ (loss) (477) 86,474
Earnings in investments in subsidiaries (79,265) (85,424)
Other operating cash flows 123,484 115,200
Net cash provided by operating activities 43,742 116,250
Cash flows from investing activities:    
Capital expenditures (29,915) (31,572)
Acquisitions, net of cash acquired 0 0
Investment in unconsolidated subsidiary (1,483,007) (166,425)
Note receivable from affiliates 0  
Gross proceeds from disposal of property, plant and equipment and other assets 1,421 897
Proceeds from insurance settlements 1,350 1,531
Payments related to routes and other intangibles (8,210) (2,374)
Net cash used by investing activities (1,518,361) (197,943)
Cash flows from financing activities:    
Proceeds from long-term debt 1,100,000  
Payments on long-term debt (256,500) 0
Borrowings from revolving credit facility 122,445  
Payments on revolving credit facility (227,445)  
Net cash overdraft financing 0  
Deferred loan costs (41,748) (11,138)
Issuance of common stock 417 32
Contributions from parent 0 0
Minimum withholding taxes paid on stock awards (6,814) (2,649)
Excess tax benefits from stock-based compensation 1,451 719
Net cash provided/ (used) by financing activities 691,806 (13,036)
Effect of exchange rate changes on cash and cash equivalents 0  
Net increase/ (decrease) in cash and cash equivalents (782,813) (94,729)
Cash and cash equivalents at beginning of period 857,267 96,945
Cash and cash equivalents at end of period 74,454 2,216
Guarantors [Member]
   
Cash flows from operating activities:    
Net income/ (loss) 86,371 79,990
Earnings in investments in subsidiaries 0 0
Other operating cash flows (11,109) (27,764)
Net cash provided by operating activities 75,262 52,226
Cash flows from investing activities:    
Capital expenditures (60,391) (54,147)
Acquisitions, net of cash acquired (645) (121,440)
Investment in unconsolidated subsidiary (1,428,542) 0
Note receivable from affiliates (204,074)  
Gross proceeds from disposal of property, plant and equipment and other assets 602 769
Proceeds from insurance settlements 200 450
Payments related to routes and other intangibles 0 0
Net cash used by investing activities (1,692,850) (174,368)
Cash flows from financing activities:    
Proceeds from long-term debt 0  
Payments on long-term debt (65) (62)
Borrowings from revolving credit facility 0  
Payments on revolving credit facility 0  
Net cash overdraft financing 0  
Deferred loan costs 0 0
Issuance of common stock 0 0
Contributions from parent 1,632,616 121,440
Minimum withholding taxes paid on stock awards 0 0
Excess tax benefits from stock-based compensation 0 0
Net cash provided/ (used) by financing activities 1,632,551 121,378
Effect of exchange rate changes on cash and cash equivalents 0  
Net increase/ (decrease) in cash and cash equivalents 14,963 (764)
Cash and cash equivalents at beginning of period 6,117 5,577
Cash and cash equivalents at end of period 21,080 4,813
Non-guarantors [Member]
   
Cash flows from operating activities:    
Net income/ (loss) (7,106) 5,434
Earnings in investments in subsidiaries 0 0
Other operating cash flows 67,399 (5,205)
Net cash provided by operating activities 60,293 229
Cash flows from investing activities:    
Capital expenditures (63,678) 0
Acquisitions, net of cash acquired (2,075,006) 0
Investment in unconsolidated subsidiary (440,615) (44,959)
Note receivable from affiliates 204,074  
Gross proceeds from disposal of property, plant and equipment and other assets 787 0
Proceeds from insurance settlements 0 0
Payments related to routes and other intangibles 0 0
Net cash used by investing activities (2,374,438) (44,959)
Cash flows from financing activities:    
Proceeds from long-term debt 736,917  
Payments on long-term debt (54,208) 0
Borrowings from revolving credit facility 47,698  
Payments on revolving credit facility (49,809)  
Net cash overdraft financing 933  
Deferred loan costs (3,475) 0
Issuance of common stock 0 0
Contributions from parent 1,719,548 44,985
Minimum withholding taxes paid on stock awards 0 0
Excess tax benefits from stock-based compensation 0 0
Net cash provided/ (used) by financing activities 2,397,604 44,985
Effect of exchange rate changes on cash and cash equivalents 6,961  
Net increase/ (decrease) in cash and cash equivalents 90,420 255
Cash and cash equivalents at beginning of period 7,473 727
Cash and cash equivalents at end of period 97,893 982
Eliminations [Member]
   
Cash flows from operating activities:    
Net income/ (loss) (79,265) (85,424)
Earnings in investments in subsidiaries 79,265 85,424
Other operating cash flows 0 0
Net cash provided by operating activities 0 0
Cash flows from investing activities:    
Capital expenditures 0 0
Acquisitions, net of cash acquired 0 0
Investment in unconsolidated subsidiary 3,352,164 166,425
Note receivable from affiliates 0  
Gross proceeds from disposal of property, plant and equipment and other assets 0 0
Proceeds from insurance settlements 0 0
Payments related to routes and other intangibles 0 0
Net cash used by investing activities 3,352,164 166,425
Cash flows from financing activities:    
Proceeds from long-term debt 0  
Payments on long-term debt 0 0
Borrowings from revolving credit facility 0  
Payments on revolving credit facility 0  
Net cash overdraft financing 0  
Deferred loan costs 0 0
Issuance of common stock 0 0
Contributions from parent (3,352,164) (166,425)
Minimum withholding taxes paid on stock awards 0 0
Excess tax benefits from stock-based compensation 0 0
Net cash provided/ (used) by financing activities (3,352,164) (166,425)
Effect of exchange rate changes on cash and cash equivalents 0  
Net increase/ (decrease) in cash and cash equivalents 0 0
Cash and cash equivalents at beginning of period 0 0
Cash and cash equivalents at end of period $ 0 $ 0